scholarly journals “LONG COVID”—A hypothesis for understanding the biological basis and pharmacological treatment strategy

2022 ◽  
Vol 10 (1) ◽  
Author(s):  
Bevyn Jarrott ◽  
Richard Head ◽  
Kirsty G. Pringle ◽  
Eugenie R. Lumbers ◽  
Jennifer H. Martin
Keyword(s):  
Treatment Strategy ◽  
Pharmacological Treatment ◽  
Biological Basis

scholarly journals Update on Pediatric non-Postoperative Junctional Ectopic Tachycardia.

2019 ◽  
Vol 2 (3) ◽  
pp. 01-09
Author(s):  
Maldonado Sebastian ◽  
Albaca Guadalupe ◽  
Lafuente María Victoria ◽  
Benjamin Monica ◽  
Lopez Jinete Darues ◽  
...  
Keyword(s):  
Natural History ◽  
Sinus Rhythm ◽  
Treatment Strategy ◽  
Pharmacological Treatment ◽  
Pediatric Patients ◽  
High Morbidity ◽  
Adequate Treatment ◽  
Junctional Ectopic Tachycardia ◽  
History Of ◽  
Multiple Drugs

Junctional ectopic tachycardia (JET) is a rare supraventricular tachycardia more frequently seen in pediatric patients which is associated with high morbidity and mortality without an adequate treatment. Its treatment often requires multiple drugs for arrhythmia control and, in some cases, a cryoablation is indicated. Some patients may revert to sinus rhythm spontaneously after long periods on antiarrhythmic drug. Currently, the arrhythmia prognosis has improved significantly since cryoablation development and the implementation of a more aggressive pharmacological treatment strategy. The purpose of this review is to describe the natural history of idiopathic JET and treatment advances.

scholarly journals Sex differences in the effects of a combined behavioral and pharmacological treatment strategy for cocaine relapse prevention in an animal model of cue exposure therapy

2020 ◽  
Vol 395 ◽  
pp. 112839
Author(s):  
Kathleen M. Kantak ◽  
Jamie M. Gauthier ◽  
Elon Mathieson ◽  
Eudokia Knyazhanskaya ◽  
Pedro Rodriguez-Echemendia ◽  
...  
Keyword(s):  
Animal Model ◽  
Sex Differences ◽  
Treatment Strategy ◽  
Pharmacological Treatment ◽  
Relapse Prevention ◽  
Exposure Therapy ◽  
Cue Exposure

scholarly journals Switching to Aripiprazole as a Strategy for Weight Reduction: A Meta-Analysis in Patients Suffering from Schizophrenia

2011 ◽  
Vol 2011 ◽  
pp. 1-6 ◽  
Author(s):  
Yoram Barak ◽  
Dov Aizenberg
Keyword(s):  
Weight Gain ◽  
Weight Reduction ◽  
Treatment Strategy ◽  
Pharmacological Treatment ◽  
Weight Control ◽  
Meta Analysis ◽  
Significant Finding ◽  
Prevention And Treatment ◽  
Treatment Of Obesity ◽  
Induce Weight Gain

Weight gain is one of the major drawbacks associated with the pharmacological treatment of schizophrenia. Existing strategies for the prevention and treatment of obesity amongst these patients are disappointing. Switching the current antipsychotic to another that may favorably affect weight is not yet fully established in the psychiatric literature. This meta-analysis focused on switching to aripiprazole as it has a pharmacological and clinical profile that may result in an improved weight control. Nine publications from seven countries worldwide were analyzed. These encompassed 784 schizophrenia and schizoaffective patients, 473 (60%) men and 311 (40%) women, mean age years. The major significant finding was a mean weight reduction by  kgs following the switch to aripiprazole (). Switching to an antipsychotic with a lower propensity to induce weight gain needs be explored as a strategy. Our analysis suggests aripiprazole as a candidate for such a treatment strategy.

Sign in / Sign up

Export Citation Format

Share Document